Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.45NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.5.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.75.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CR.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BT.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.37 (Lambda)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.14 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.7.1 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.2 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.112 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.10 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.102 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.124 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.46.6 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.43.3 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.119.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.25.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.122.6 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.621.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.39.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.125 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.103.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.92 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.122.4 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.101 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.57NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.49NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.9.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.69NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.560NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.610NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.10 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.286NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used